Results 111 to 120 of about 22,001 (226)

Normalization of activated partial thromboplastin time and diluted Russell's viper venom time ratios can be safely omitted in the assessment of lupus anticoagulant. [PDF]

Res Pract Thromb Haemost
Kimiaei A, Antovic J, Gran C.
europepmc   +1 more source

Quantifying Lupus Anticoagulant Interference in Intrinsic Coagulation Factor Activity Assays and Evaluating the Corrective Performance of the SCT-Based Method. [PDF]

Clin Appl Thromb Hemost
Yang Y, Li Y, Jiang A, Lu Y, You R, Miao L, Qin R, Zhu Z, Xing Y, Qu C.   +9 more
europepmc   +1 more source

Determining Thrombogenicity: Using a Modified Thrombin Generation Assay to Detect the Level of Thrombotic Event Risk in Lupus Anticoagulant-Positive Patients. [PDF]

Biomedicines, 2023
Bradáčová P, Slavík L, Úlehlová J, Kriegová E, Jará E, Bultasová L, Friedecký D, Ullrychová J, Procházková J, Hluší A, Manukyan G, Štefaničková L.   +11 more
europepmc   +1 more source

Waldenström's macroglobulinaemia secreting a paraprotein with lupus anticoagulant activity: possible association with gastrointestinal tract disease and malabsorption. [PDF]

, 1993
Robert C. Tait, P K Oogarah, John Houghton, S E Farrand, M R Haeney   +4 more
openalex   +1 more source

Pitfalls in Coagulation Testing: A Pediatric Case of Lupus Anticoagulant Hypoprothrombinemia Syndrome Following Enterocolitis. [PDF]

Cureus
Homma T, Kamio T, Oishi K, Amano K, Akiyama M.   +4 more
europepmc   +1 more source

Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation. [PDF]

Clin Appl Thromb Hemost, 2023
Kornfehl A, Brock R, Staudinger T, Schellongowski P, Nagler B, Hermann A, Robak O, Schwameis M, Quehenberger P, Buchtele N.   +9 more
europepmc   +1 more source

Lupus Anticoagulant Positivity as a Risk Marker for Hemolytic Anemia in Patients with APS. [PDF]

Medicina (Kaunas)
Kang JH.
europepmc   +1 more source

Retracted: Application Value of Combined Detection of Anti-β2-GPI, ACL, and Lupus Anticoagulant in the Diagnosis of Patients with Antiphospholipid Syndrome. [PDF]

Evid Based Complement Alternat Med, 2023
And Alternative Medicine EC.
europepmc   +1 more source

Lupus anticoagulant in pediatric populations: A comprehensive review of clinical Presentation, diagnostic approaches, and management strategies [PDF]

Baraa Ahmed Saeed, Ahmed Abdulraheem Ibrahim Dahy, Anwer Jaber Faisal, Bassam Shaker Mahmood   +3 more
openalex   +1 more source

Lupus anticoagulants and anti‐phospholipid antibodies as risk factors for a first episode of ischemic stroke [PDF]

, 2009
Sarra Saidi, Touhami Mahjoub, Wassim Y. Almawi   +2 more
openalex   +1 more source